Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Grace S. Hubel & Angela D. Moreland. (2020) What do adolescent parents need to prevent repeat pregnancy? A qualitative investigation. Vulnerable Children and Youth Studies 15:1, pages 21-31.
Read now
Read now
I. Piva, F. Brusca, F. Tassinati, S. Bonipozzi, A. Palano, M. T. Sassi, G. Bonaccorsi, D. Morano, R. Martinello, G. Scutiero, U. Indraccolo & P. Greco. (2019) Post-abortion long-acting reversible contraception in a sample of Italian women: intrauterine device versus subdermal implant. Gynecological Endocrinology 35:5, pages 427-433.
Read now
Read now
Sally Rafie, Rebecca H Stone, Tracey A Wilkinson, Laura M Borgelt, Shareen Y El-Ibiary & Denise Ragland. (2017) Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects. Integrated Pharmacy Research and Practice 6, pages 99-108.
Read now
Read now
Articles from other publishers (27)
Iason Psilopatis, Kleio Vrettou, Florian Nima Fleckenstein & Stamatios Theocharis. (2023) The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities. Cells 12:9, pages 1227.
Crossref
Crossref
Casandra Dolovich, Leigh Anne Shafer, Lesley A. Graff, Kathy Vagianos, Kelcie Witges, Laura E. Targownik & Charles N. Bernstein. (2023) Hormonal Contraceptives Reduce Active Symptomatic Disease but May Increase Intestinal Inflammation in IBD. Journal of Clinical Gastroenterology Publish Ahead of Print.
Crossref
Crossref
Suraj Fanse, Quanying Bao & Diane J. Burgess. (2022) Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities. Advanced Drug Delivery Reviews 191, pages 114581.
Crossref
Crossref
Karina Castillo, Kevin Zambrano, Diego Barba, Paola Robayo, Serena Sanon, Andres Caicedo & Alfredo Jose Jijon Chiriboga. (2022) Long-acting reversible contraceptives effects in abnormal uterine bleeding, a review of the physiology and management. European Journal of Obstetrics & Gynecology and Reproductive Biology 270, pages 231-238.
Crossref
Crossref
Rita Palmeira-de-Oliveira, Ana Sofia Oliveira, Joana Rolo, Mariana Tomás, Ana Palmeira-de-Oliveira, Sérgio Simões & José Martinez-de-Oliveira. (2022) Women’s preferences and acceptance for different drug delivery routes and products. Advanced Drug Delivery Reviews 182, pages 114133.
Crossref
Crossref
Bi Jiang, Wei-Chao He, Jing-Yun Yu, Si-Si Wei & Xin-Jian Zhang. (2021) History of IUD utilization and the risk of preterm birth: a cohort study. Archives of Gynecology and Obstetrics 305:2, pages 349-358.
Crossref
Crossref
Kidane G. Haileyes, Hussen M. Asfaw, Siraye G. Ayele & Leul D. Kitawu. (2023) Myth and misconception about long-acting reversible contraception use among reproductive age group women in Debre Berhan governmental health centers, Ethiopia: qualitative study. Global Reproductive Health 8:1, pages e65-e65.
Crossref
Crossref
Sarah G. Franklin, Maya O’Neal, Ambreanna Arneus, Calvin Colvin, Maung Aung & Pauline E. Jolly. (2021) Effectiveness of an intrauterine device informative intervention among post-natal women in Western Jamaica. Reproductive Health 18:1.
Crossref
Crossref
Zaida Urbán-Morlán, Luis Eduardo Serrano-Mora, Lizbeth Martínez-Acevedo, Gerardo Leyva-Gómez, Néstor Mendoza-Muñoz & David Quintanar-Guerrero. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
601
622
.
Ziliang Wang, Wei Yuan, Xiaowen Tu, Hong Liang, Maohua Miao, Yan Cheng, Longmei Jin & Chaohua Lou. (2020) Misconceptions and Beliefs Regarding the Use of Intrauterine Devices for Nulliparous Women Among Chinese Health Care Providers. Journal of Pediatric and Adolescent Gynecology 33:1, pages 33-38.
Crossref
Crossref
OluwasomidoyinO Bello & AdebayoD Agboola. (2020) Trends in contraceptive uptake at a tertiary health facility in Ibadan, Nigeria. International Journal of Medicine and Health Development 25:1, pages 21.
Crossref
Crossref
Ziliang Wang, Chaohua Lou, Longmei Jin, Maohua Miao, Xiaowen Tu, Hong Liang, Yan Cheng & Wei Yuan. (2019) Attitudes and practices related to intrauterine devices for nulliparous women among Chinese health care providers. Reproductive Health 16:1.
Crossref
Crossref
Mohammad S. Alyahya, Heba H. Hijazi, Hussam A. Alshraideh, Nihaya A. Al-sheyab, Dana Alomari, Sara Malkawi, Sarah Qassas, Samah Darabseh & Yousef S. Khader. (2019) Do modern family planning methods impact women’s quality of life? Jordanian women’s perspective. Health and Quality of Life Outcomes 17:1.
Crossref
Crossref
Michelle Lende, Emily Freeman, Rakin Hoq, Connie Cottrell & Jennifer Savitski. (2019) Multidisciplinary Approach to Managing an Obstetrical Patient with Delusional Denial of Pregnancy. Psychiatric Annals 49:11, pages 506-508.
Crossref
Crossref
Pauline Bosco-Lévy, Amandine Gouverneur, Claire Langlade, Ghada Miremont & Antoine Pariente. (2019) Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study. Contraception 99:6, pages 345-349.
Crossref
Crossref
Manish Gehani, Manoj Pal, Anupama Arya, Shobhana Singh, Kaushik S., Kathryn A. O’Connell, Levent Cagatay, Sumon Sengupta & Sunita Singal. (2020) Potential for Improving Intrauterine Device (IUD) Service Delivery Quality: Results from a Secondary Data Analysis. Gates Open Research 3, pages 1473.
Crossref
Crossref
Manish Gehani, Manoj Pal, Anupama Arya, Shobhana Singh, Kaushik S., Kathryn A. O’Connell, Levent Cagatay, Sumon Sengupta & Sunita Singal. (2019) Could EAISI-trained providers provide better quality of IUD services? Results of a secondary data analysis of complications as a proxy indicator. Gates Open Research 3, pages 1473.
Crossref
Crossref
Manish Gehani, Manoj Pal, Anupama Arya, Shobhana Singh, Kaushik S., Kathryn A. O’Connell, Levent Cagatay, Sumon Sengupta & Sunita Singal. (2019) Could trained providers provide better quality of IUD services? Results of a secondary data analysis of complications as a proxy indicator. Gates Open Research 3, pages 1473.
Crossref
Crossref
Fred Yao Gbagbo & Esinam Afi Kayi. (2018) Use and discontinuation of intrauterine contraceptive device in the Greater Accra Region of Ghana. Contraception and Reproductive Medicine 3:1.
Crossref
Crossref
Iliescu Dominic Gabriel, Ștefania Tudorache, Simona Vlădăreanu, Nuți Daniela Oprescu, Maria Cezara Mureșan, Roxana Cristina Drăgușin & Iuliana Ceaușu. 2018. Family Planning. Family Planning.
Nancy Fugate Woods & Gloria Bachmann. (2017) Contraception for midlife women: lack of information? Lack of interest? Lack of investment?. Women's Midlife Health 3:1.
Crossref
Crossref
Justine P. Wu, Michael M. McKee, Kimberly S. Mckee, Michelle A. Meade, Melissa Plegue & Ananda Sen. (2017) Female sterilization is more common among women with physical and/or sensory disabilities than women without disabilities in the United States. Disability and Health Journal 10:3, pages 400-405.
Crossref
Crossref
David K. Turok, David L. Eisenberg, Stephanie B. Teal, Lisa M. Keder & Mitchell D. Creinin. (2016) A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement. American Journal of Obstetrics and Gynecology 215:5, pages 599.e1-599.e6.
Crossref
Crossref
Cary C. Cotton, Donna Baird, Robert S. Sandler & Millie D. Long. (2016) Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis. Inflammatory Bowel Diseases 22:7, pages 1631-1638.
Crossref
Crossref
Kim Angelini. (2016) A Lower-Cost Option for Intrauterine Contraception. Nursing for Women's Health 20:2, pages 197-202.
Crossref
Crossref
Ignacio Cristobal, Luis Ignacio Lete, Esther de la Viuda, Nuria Perulero, Agnes Arbat & Ignasi Canals. (2016) One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users. Contraception 93:4, pages 367-371.
Crossref
Crossref
David L. Eisenberg, Courtney A. Schreiber, David K. Turok, Stephanie B. Teal, Carolyn L. Westhoff & Mitchell D. Creinin. (2015) Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception 92:1, pages 10-16.
Crossref
Crossref